LumaCyte
Health Care · Biologics & Biosimilars
Overview
Real‑time bioprocess analytics and predictive cell phenotyping with LumaCyte’s label‑free single‑cell insights to improve ATMP and biologics production consistency and quality.
Key facts
These are the key facts about LumaCyte on Alion as of Nov 13, 2026. LumaCyte is headquartered in Charlottesville, United States. It has raised $19.9M in 7 funding rounds. The latest round is Venture - Series Unknown of $10M, announced in 2023.
- Headquarters
- Charlottesville, United StatesAlion company profile, updated Nov 9, 2026
- Employees
- 50+Alion company profile, an estimated range
- Total raised
- $19.9MSum of 7 equity rounds Alion knows
- Latest round
- Venture - Series Unknown · $10M · Aug 21, 2023SEC Form D filing · sec.gov
Official records
Visa sponsorship
0
H-1B filings in 12 months
0
Open roles in United States
In the register as Lumacyte, Inc., Charlottesville, VA
Other sponsors in the same field
Kashiv Biosciences 17 filings
Rani Therapeutics 2 filings
Kaigene 1 filings
SELLAS Life Sciences Group 1 filings
Alert me
US Department of Labor · latest filing Nov 19, 2024 · Visa details by country
Financials
Total raised
$19.9M
Latest round
Venture - Series Unknown
Funding rounds
7
Funding rounds
People
Sean Hart
Executive Officer, Director
Renee Hart
Executive Officer, Director
Paul Meister
Director
Robert Heiser
Director
Dennis Walczewski
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Charlottesville
United States
HQ
Contact Us - LumaCyte
50-200 est. staff
1145 River Rd Suite 1, Charlottesville, 22901
How to cite this page
Alion, "LumaCyte: key facts", as of Nov 13, 2026. https://alion.io/company/lumacyte
These figures are published under a free licence. You may reuse them, including commercially, as long as you credit Alion and link back to this page. CC BY-SA 4.0